A controlled release pharmaceutical composition comprising a strontium salt. The invention also relates to the use of a strontium salt for treating a male suffering from diseases and conditions affecting metabolism and/or structural integrity of cartilage and/or bone. The invention also relates to the use of a strontium-containing compound for preventing a cartilage and/or bone condition in a subject, and for the treatment and/or prophylaxis of secondary osteoporosis.
|Publication status||Published - Mar 31 2005|
Hansen, C., Nilsson, H., Andersen, J., & Christgau, S. (2005). Controlled release composition containing a strontium salt. (Patent No. WO2004098617A3). https://patentimages.storage.googleapis.com/71/a8/1d/6bf31ae6e02557/WO2004098617A3.pdf